AP, D., AM, M., GA, M., MF, d. A., RR, F., & SS, P. (2016). The impact of laronidase treatment in otolaryngological manifestations of patients with mucopolysaccharidosis. Brazilian journal of otorhinolaryngology, 82(5), 522. https://doi.org/10.1016/j.bjorl.2015.09.006
Chicago Style (17th ed.) CitationAP, Dualibi, Martins AM, Moreira GA, de Azevedo MF, Fujita RR, and Pignatari SS. "The Impact of Laronidase Treatment in Otolaryngological Manifestations of Patients with Mucopolysaccharidosis." Brazilian Journal of Otorhinolaryngology 82, no. 5 (2016): 522. https://doi.org/10.1016/j.bjorl.2015.09.006.
MLA (9th ed.) CitationAP, Dualibi, et al. "The Impact of Laronidase Treatment in Otolaryngological Manifestations of Patients with Mucopolysaccharidosis." Brazilian Journal of Otorhinolaryngology, vol. 82, no. 5, 2016, p. 522, https://doi.org/10.1016/j.bjorl.2015.09.006.